News & Insights

The SEC will permit mandatory shareholder arbitration in public company governance starting September 19, 2025, marking a significant shift in federal securities law claims

Gunderson Dettmer’s year-in-review venture capital report analyzes data collected from the thousands of venture financing transactions in which we have represented clients, featuring insights from partners Maggie White, Jose Rivera, and Nick Harley

Gunderson Dettmer represented client Encodia, a biotech company developing next-generation solutions for proteomics research, in its $75 million Series C financing led by Northpond Ventures and Deerfield Management.

Gunderson Dettmer Advisor and former Gilead General Counsel Brett Pletcher hosts the third-part of his three-part webinar series, "Building the General Counsel Role in Venture-Backed Companies"

Gunderson Dettmer Advisor and former Gilead General Counsel Brett Pletcher hosts the second-part of his three-part webinar series on “Building the General Counsel Role in Venture-Backed Companies”

Gunderson Dettmer Advisor and former Gilead General Counsel Brett Pletcher to host a free, three-part series of webinars to help GCs and heads of legal assess the challenges that may be constraining their current roles, identify and develop the relationships necessary to grow their roles and create strategies for building their roles and functions over time.

Findigs announces its $32 million Series C financing. 

Gunderson Dettmer represented the four lead investors – Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital – and several other investors in the $65 billion Series H financing of Anthropic, PBC the category leader in enterprise AI.

Andreessen Horowitz led the $250 million Series C financing of Exa, valuing the company at $2.2 billion.

Gunderson Dettmer is ranked as the most active venture capital law firm globally in PitchBook’s Q1 2026 Global League Tables, maintaining the top spot for another consecutive quarter and reinforcing its role as the most trusted advisor to investors and companies at every stage.

LMG Life Sciences recognizes Gunderson Dettmer with Impact Deal of the Year and names Boston associate Joel Diamond the US Rising Star—Financial and Corporate in its 2025 Life Sciences Americas Awards